Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 4 Open-market sale Chief Financial Officer sold 3,900 shares at $27.00 ($105,300)
  2. 4 Open-market sale Chief Scientific Officer sold 11,333 shares at an average $27.95 ($316,722)
  3. 4 Open-market sale Chief Financial Officer sold 3,900 shares at $28.30 ($110,365)
  4. 4 Open-market sale Director sold 53,583 shares at an average $27.52 ($1,474,677)
  5. 4 Open-market sale Chief Scientific Officer sold 11,333 shares at an average $27.40 ($310,523)
  6. 8-K Event Other events
  7. 4 Open-market sale Chief Financial Officer sold 3,900 shares at $28.19 ($109,955)
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. 8-K Event Other events
  11. 4 Open-market sale Chief Scientific Officer sold 11,333 shares at $27.53 ($312,042)
  12. 8-K Event Material agreement
  13. 424B5 Offering Prospectus
  14. 4 Open-market sale Chief Financial Officer sold 3,900 shares at $30.62 ($119,403)
  15. 8-K Event Other events
  16. 8-K Event Other events
  17. 4 Open-market sale Chief Scientific Officer sold 11,333 shares at an average $25.69 ($291,201)
  18. CT ORDER Other Confidential Order
  19. 4 Open-market sale Chief Financial Officer sold 3,900 shares at $29.88 ($116,550)
  20. 8-K Event Agreement ended

Page 35 of 47 · 923 filings